Debate: Optimal approach for stage III NSCLC - Trimodality therapy

In this presentation from the 18th European Congress: Perspectives in Lung Cancer, Dr. Paul Van Schil arguest that trimodality therapy is the optimal approach for stage III non-small cell lung cancer ... Author: imedex Added: 08/14/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts